BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11392620)

  • 21. Alanine scanning mutagenesis of conserved arginine/lysine-arginine/lysine-X-X-arginine/lysine G protein-activating motifs on m1 muscarinic acetylcholine receptors.
    Lee NH; Geoghagen NS; Cheng E; Cline RT; Fraser CM
    Mol Pharmacol; 1996 Jul; 50(1):140-8. PubMed ID: 8700106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural basis of receptor/G protein coupling selectivity studied with muscarinic receptors as model systems.
    Wess J; Liu J; Blin N; Yun J; Lerche C; Kostenis E
    Life Sci; 1997; 60(13-14):1007-14. PubMed ID: 9121341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insertion mutagenesis as a tool to predict the secondary structure of a muscarinic receptor domain determining specificity of G-protein coupling.
    Blüml K; Mutschler E; Wess J
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):7980-4. PubMed ID: 8058746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Agonist activation of muscarinic acetylcholine receptors.
    Hulme EC; Curtis CA; Page KM; Jones PG
    Cell Signal; 1993 Nov; 5(6):687-94. PubMed ID: 8130073
    [No Abstract]   [Full Text] [Related]  

  • 25. Molecular basis of receptor/G protein coupling selectivity studied by coexpression of wild type and mutant m2 muscarinic receptors with mutant G alpha(q) subunits.
    Kostenis E; Conklin BR; Wess J
    Biochemistry; 1997 Feb; 36(6):1487-95. PubMed ID: 9063897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of a disulfide cross-linking strategy to study muscarinic receptor structure and mechanisms of activation.
    Zeng FY; Hopp A; Soldner A; Wess J
    J Biol Chem; 1999 Jun; 274(23):16629-40. PubMed ID: 10347230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of two highly conserved tyrosine residues in the m1 muscarinic receptor second transmembrane domain in ligand binding and receptor function.
    Lee SY; Zhu SZ; el-Fakahany EE
    Recept Signal Transduct; 1996; 6(1):43-52. PubMed ID: 8933621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Constitutive activation of the m5 muscarinic receptor by a series of mutations at the extracellular end of transmembrane 6.
    Spalding TA; Burstein ES; Wells JW; Brann MR
    Biochemistry; 1997 Aug; 36(33):10109-16. PubMed ID: 9254607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolutionary trace of G protein-coupled receptors reveals clusters of residues that determine global and class-specific functions.
    Madabushi S; Gross AK; Philippi A; Meng EC; Wensel TG; Lichtarge O
    J Biol Chem; 2004 Feb; 279(9):8126-32. PubMed ID: 14660595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple allosteric sites on muscarinic receptors.
    Birdsall NJ; Lazareno S; Popham A; Saldanha J
    Life Sci; 2001 Apr; 68(22-23):2517-24. PubMed ID: 11392621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha-helical distorting substitution disrupt coupling between m3 muscarinic receptor and G proteins.
    Duerson K; Carroll R; Clapham D
    FEBS Lett; 1993 Jun; 324(1):103-8. PubMed ID: 7684986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural determinants for the interactions between muscarinic toxin 7 and muscarinic acetylcholine receptors.
    Xu J; Zhao H; Zheng Z; Wang Y; Niu Y; Wang H; Xu J; Lu Y; Chen H
    J Mol Recognit; 2015 Apr; 28(4):239-52. PubMed ID: 25683330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure/function relationships of muscarinic acetylcholine receptors.
    Brann MR; Klimkowski VJ; Ellis J
    Life Sci; 1993; 52(5-6):405-12. PubMed ID: 7680090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Refinement of a homology model of the mu-opioid receptor using distance constraints from intrinsic and engineered zinc-binding sites.
    Fowler CB; Pogozheva ID; LeVine H; Mosberg HI
    Biochemistry; 2004 Jul; 43(27):8700-10. PubMed ID: 15236578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacology of a constitutively active muscarinic receptor generated by random mutagenesis.
    Spalding TA; Burstein ES; Brauner-Osborne H; Hill-Eubanks D; Brann MR
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1274-9. PubMed ID: 8531092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allosteric site on muscarinic acetylcholine receptors: identification of two amino acids in the muscarinic M2 receptor that account entirely for the M2/M5 subtype selectivities of some structurally diverse allosteric ligands in N-methylscopolamine-occupied receptors.
    Voigtländer U; Jöhren K; Mohr M; Raasch A; Tränkle C; Buller S; Ellis J; Höltje HD; Mohr K
    Mol Pharmacol; 2003 Jul; 64(1):21-31. PubMed ID: 12815157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutational analysis and molecular modeling of the binding pocket of the metabotropic glutamate 5 receptor negative modulator 2-methyl-6-(phenylethynyl)-pyridine.
    Malherbe P; Kratochwil N; Zenner MT; Piussi J; Diener C; Kratzeisen C; Fischer C; Porter RH
    Mol Pharmacol; 2003 Oct; 64(4):823-32. PubMed ID: 14500738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis.
    Matsui H; Lazareno S; Birdsall NJ
    Mol Pharmacol; 1995 Jan; 47(1):88-98. PubMed ID: 7838137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets?
    Bissantz C; Bernard P; Hibert M; Rognan D
    Proteins; 2003 Jan; 50(1):5-25. PubMed ID: 12471595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.